Wang Ting, Garcia Joe Gn, Zhang Wei
Section of Pulmonary, Critical Care, Allergy & Sleep Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA ; Institute for Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Curr Pharmacogenomics Person Med. 2012 Dec;10(4):314-321. doi: 10.2174/187569212803901792.
Particulate matter (PM) air pollution exerts significant adverse health effects in global populations, particularly in developing countries with extensive air pollution. Understanding of the mechanisms of PM-induced health effects including the risk for cardiovascular diseases remains limited. In addition to the direct cellular physiological responses such as mitochondrial dysfunction and oxidative stress, PM mediates remarkable dysregulation of gene expression, especially in cardiovascular tissues. The PM-mediated gene dysregulation is likely to be a complex mechanism affected by various genetic and non-genetic factors. Notably, PM is known to alter epigenetic markers (e.g., DNA methylation and histone modifications), which may contribute to air pollution-mediated health consequences including the risk for cardiovascular diseases. Notably, epigenetic changes induced by ambient PM exposure have emerged to play a critical role in gene regulation. Though the underlying mechanism(s) are not completely clear, the available evidence suggests that the modulated activities of DNA methyltransferase (DNMT), histone acetylase (HAT) and histone deacetylase (HDAC) may contribute to the epigenetic changes induced by PM or PM-related chemicals. By employing genome-wide epigenomic and systems biology approaches, PM toxicogenomics could conceivably progress greatly with the potential identification of individual epigenetic loci associated with dysregulated gene expression after PM exposure, as well the interactions between epigenetic pathways and PM. Furthermore, novel therapeutic targets based on epigenetic markers could be identified through future epigenomic studies on PM-mediated cardiopulmonary toxicities. These considerations collectively inform the future population health applications of genomics in developing countries while benefiting global personalized medicine at the same time.
颗粒物(PM)空气污染对全球人群的健康产生重大不利影响,尤其是在空气污染严重的发展中国家。对PM诱导的健康影响机制的理解,包括心血管疾病风险的理解仍然有限。除了直接的细胞生理反应如线粒体功能障碍和氧化应激外,PM还介导基因表达的显著失调,特别是在心血管组织中。PM介导的基因失调可能是一种受多种遗传和非遗传因素影响的复杂机制。值得注意的是,已知PM会改变表观遗传标记(如DNA甲基化和组蛋白修饰),这可能导致空气污染介导的健康后果,包括心血管疾病风险。值得注意的是,环境PM暴露诱导的表观遗传变化已在基因调控中发挥关键作用。虽然潜在机制尚不完全清楚,但现有证据表明,DNA甲基转移酶(DNMT)、组蛋白乙酰转移酶(HAT)和组蛋白去乙酰化酶(HDAC)的调节活性可能导致PM或PM相关化学物质诱导的表观遗传变化。通过采用全基因组表观基因组学和系统生物学方法,PM毒理基因组学有望取得重大进展,有可能识别出与PM暴露后基因表达失调相关的个体表观遗传位点,以及表观遗传途径与PM之间的相互作用。此外,通过未来对PM介导的心肺毒性的表观基因组学研究,可以确定基于表观遗传标记的新型治疗靶点。这些考虑共同为发展中国家基因组学在未来人群健康中的应用提供了信息,同时也造福于全球个性化医疗。